Traditional Chinese Medicine Improves the Development of Vascular Thrombotic Inflammation: The Key Role of Gut Microbiota and Its Derived Metabolites
Phytotherapy Research · 2025
DOI: 10.1002/ptr.70012 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, 2025. Written by Jingjing Xu and 5 co-authors. Institution: School of Pharmacy, Guangdong Pharmaceutical University, Guangdong, China. Major MEDLINE topics: Gastrointestinal Microbiome, Medicine, Chinese Traditional, Thrombosis, Inflammation. Cited 2 times so far (Crossref); 200 references. Funded by: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (original language)
Vascular thrombotic inflammation is the most serious complication of cardiovascular disease, and the platelet and coagulation cascades are effective targets for antithrombotic methods. However, the application of traditional antiplatelet drugs is limited to a certain extent due to their various side effects, such as bleeding risk and drug resistance. New evidence showed that gut microbiota is considerably associated with thrombotic inflammation, and targeted microbial pathways can promote beneficial ‘antiplatelet’ effects and decrease the promotion of thrombosis, without bleeding complications. Owing to the advantages of multiple components and targets, traditional Chinese medicines (TCMs) can affect vascular thrombotic inflammation by regulating the composition of the gut microbiota, improving the intestinal mucosal barrier, and affecting the level of gut microbiota‐derived metabolites. Targeting gut microbiota pathways using TCM is a promising therapeutic strategy for suppressing thrombotic inflammation. TCMs also exhibit beneficial effects in treating patients with various thrombosis‐related inflammatory conditions owing to the antithrombotic and anti‐inflammatory properties. In this review, we introduce and summarize the most recent research advances in gut microbiota and vascular thrombotic inflammation, highlighting the role of the gut microbiota. In addition, a comprehensive overview of the regulation of vascular thrombotic inflammation using TCMs that target gut microbiota, and limitations and prospects of the current research are discussed. This study provides new insights for treating vascular thrombosis inflammatory diseases and lays a foundation for future research.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Pharmacy, Guangdong Pharmaceutical University, Guangdong, China.
- Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- School of Pharmacy, Naval Medical University, Shanghai, China.
- Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
ORCID profiles: Gaosong Wu
Funding
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Cite
APA
Xu, J., Zhang, Y., Liao, J., Le, W., Wu, G., & Zhang, W. (2025). Traditional Chinese Medicine Improves the Development of Vascular Thrombotic Inflammation: The Key Role of Gut Microbiota and Its Derived Metabolites. Phytotherapy Research. https://doi.org/10.1002/ptr.70012
Vancouver
Xu J, Zhang Y, Liao J, Le W, Wu G, Zhang W. Traditional Chinese Medicine Improves the Development of Vascular Thrombotic Inflammation: The Key Role of Gut Microbiota and Its Derived Metabolites. Phytotherapy Research. 2025. doi:10.1002/ptr.70012
BibTeX
@article{Xu2025,
author = {Xu, Jingjing and Zhang, Yuhao and Liao, Jingyu and Le, Wanqi and Wu, Gaosong and Zhang, Weidong},
title = {Traditional Chinese Medicine Improves the Development of Vascular Thrombotic Inflammation: The Key Role of Gut Microbiota and Its Derived Metabolites},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.70012}
}
EUVIMED